A
Alice B. Kornblith
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 60
Citations - 11140
Alice B. Kornblith is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer & Quality of life. The author has an hindex of 39, co-authored 60 publications receiving 10487 citations. Previous affiliations of Alice B. Kornblith include Harvard University & Washington University in St. Louis.
Papers
More filters
Journal ArticleDOI
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
Lewis R. Silverman,Erin P. Demakos,Bercedis L. Peterson,Alice B. Kornblith,Jimmie C. Holland,Rosalie Odchimar-Reissig,Richard Stone,Douglas A. Nelson,Bayard L. Powell,Carlos M. DeCastro,John Ellerton,Richard A. Larson,Charles A. Schiffer,James F. Holland +13 more
TL;DR: Aza C treatment results in significantly higher response rates, improved quality of life, reduced risk of leukemic transformation, and improved survival compared with supportive care.
Journal ArticleDOI
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress
Russell K. Portenoy,Howard T. Thaler,Alice B. Kornblith,J. McCarthy Lepore,Hamutal Friedlander-Klar,E. Kiyasu,K. Sobel,N. Coyle,Nancy E. Kemeny,Larry Norton,Howard I. Scher +10 more
TL;DR: High correlations with clinical status and quality of life measures support the validity of the MSAS and indicate the utility of several subscale scores, including PSYCH, PHYS, and a brief Global Distress Index.
Journal ArticleDOI
Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study.
Andrew J. Roth,Alice B. Kornblith,Laure Batel-Copel,Elizabeth Peabody,Howard I. Scher,Jimmie C. Holland +5 more
TL;DR: As more oncology care is moved to the outpatient setting, the need for a rapid means for oncologists to identify patients with significant distress has increased and the likelihood that a distressed patient will not be recognized and will remain untreated in the current health care environment.
Journal ArticleDOI
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
Patricia J. Eifel,Axelson Ja,Costa J,Crowley J,Curran Wj,Deshler A,Fulton S,Hendricks Cb,Kemeny M,Alice B. Kornblith,Louis Ta,Markman M,Robert J. Mayer,Roter D +13 more
TL;DR: Adjuvant hormonal therapy should be offered only to women whose tumors express hormone receptor protein in tumor tissues, and quality of life needs to be evaluated in selected randomized clinical trials to examine the impact of the major acute and long-term side effects of adjuvant treatments.
Journal ArticleDOI
Symptom prevalence, characteristics and distress in a cancer population
Russell K. Portenoy,Howard T. Thaler,Alice B. Kornblith,J. McCarthy Lepore,Hamutal Friedlander-Klar,N. Coyle,T. Smart-Curley,Nancy E. Kemeny,Larry Norton,William J. Hoskins,Howard I. Scher +10 more
TL;DR: In this article, a validation study of a new symptom assessment instrument, inpatients and outpatients with prostate, colon, breast or ovarian cancer were evaluated using the Memorial Symptom Assessment Scale and other measures of psychological condition, performance status, symptom distress and overall quality of life.